The subcutaneous implantable cardioverter defibrillator (ICD) provides therapy for the
prevention of sudden cardiac death while avoiding the numerous complications associated …

The subcutaneous implantable cardioverter defibrillator (S-ICD) is a completely
extrathoracic device that has recently been FDA approved for the prevention of sudden …

Multiple randomized, multicenter trials have established the role of the implantable
cardioverter-defibrillator (ICD) in the treatment and prevention of sudden cardiac death …

Background Implantable cardioverter–defibrillators (ICDs) prevent sudden death from
cardiac causes in selected patients but require the use of transvenous lead systems. To …

Although conventional implantable cardioverter-defibrillators (ICDs) have proved effective in
the prevention of sudden cardiac death (SCD), they still appear to be limited by non-trivial …

The completely subcutaneous implantable cardioverter defibrillator (S-ICD) is rapidly
evolving to become a complete alternative for the transvenous ICD (TV-ICD) leaving the …

The subcutaneous implantable cardioverter-defibrillator (S-ICD) system is an established
therapy for prevention of sudden cardiac death (SCD) and an alternative to a transvenous …

The subcutaneous implantable cardioverter-defibrillator (S-ICD) is a novel technology for the
treatment of sudden cardiac death. The system consists of a pulse generator implanted in …

BACKGROUND: Implantable cardioverter-defibrillators (ICDs) are widely used to prevent
fatal outcomes associated with life-threatening arrhythmic episodes in a variety of cardiac …

The recent introduction of subcutaneous implantable cardioverter defibrillator (S-ICD) has
raised attention about the potential of this technology for clinical use in daily clinical practice …